UNITED THERAPEUTICS Corp 4

United Therapeutics director Judy D. Olian received an annual award of 760 restricted stock units on July 22, 2026.

On July 22, 2026, United Therapeutics Corporation non-employee director Judy D. Olian received an annual equity grant of 760 restricted stock units (RSUs), each representing the right to receive one share of common stock upon vesting. The award is characterized as a routine annual non-employee director grant that will become fully vested on the earlier of the one-year anniversary of the grant date or the date of the next Annual Meeting of Shareholders, anticipated to be June 25, 2027. There was no purchase or sale for cash consideration disclosed, and the RSUs have no expiration date. Following this grant, Olian’s directly owned common stock position is shown as 5,555 shares, with the RSUs adding to her overall equity-linked exposure to the company.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0001605729-26-000013

Alert Tier

5